IL10 and viral myocarditis: Other findings suggest that IL-10-producing B cells may be a new therapeutic target for modulating the immune response in viral myocarditis, once IL-10-producing B cells negatively regulated the levels of T-bet and RORγt mRNA, decreasing the proportions of Th1 and Th17 cells to relieve inflammatory damage at an early stage of the disease [126].